Antonella R. Favit-Van Pelt - Jul 2, 2024 Form 4 Insider Report for HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)

Role
Chief Medical Officer
Signature
/s/ Emily Johns, by Power of Attorney
Stock symbol
HSDT
Transactions as of
Jul 2, 2024
Transactions value $
$0
Form type
4
Date filed
7/5/2024, 05:00 PM
Previous filing
Feb 16, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HSDT Stock Option (Right to Buy) Award $0 +277K $0.00 277K Jul 2, 2024 Class A Common Stock 277K $0.97 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 62.5% of the options vested immediately upon grant, and the remaining options vest in a series of ten (10) successive equal quarterly installments on the last day of each quarter starting on September 30, 2024, subject to the Reporting Person's continued service through each applicable vesting period.